U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
195901195901Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaCompletedNo Results AvailableOvarian Cancer|Sarcoma|Small Intestine CancerBiological: filgrastim|Drug: docetaxel|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00004066
195902195902Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerCompletedNo Results AvailableBladder Cancer|Breast Cancer|Colorectal Cancer|Gastric Cancer|Head and Neck Cancer|Kidney Cancer|Leukemia|Lung Cancer|Melanoma (Skin)|Ovarian Cancer|Prostate Cancer|Unspecified Adult Solid Tumor, Protocol SpecificDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00004065
195903195903Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal CancerActive, not recruitingNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerBiological: oregovomabhttps://ClinicalTrials.gov/show/NCT00004064
195904195904Cisplatin, Gemcitabine, Interferon Alfa, and Hyperthermia in Treating Patients With Advanced CancerRecruitingNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: recombinant interferon alfa|Drug: cisplatin|Drug: gemcitabine hydrochloride|Procedure: hyperthermia treatmenthttps://ClinicalTrials.gov/show/NCT00004063
195905195905Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid CancerCompletedNo Results AvailableHead and Neck CancerDrug: azacitidine|Drug: liothyronine sodium|Radiation: iodine I 131https://ClinicalTrials.gov/show/NCT00004062
195906195906Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Oral ComplicationsBiological: filgrastim|Biological: palifermin|Drug: cyclophosphamide|Drug: etoposide|Drug: ifosfamide|Procedure: peripheral blood stem cell transplantation|Procedure: quality-of-life assessment|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00004061
195907195907Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal CancerCompletedNo Results AvailableFallopian Tube Cancer|Ovarian Cancer|Primary Peritoneal Cavity CancerDrug: exatecan mesylatehttps://ClinicalTrials.gov/show/NCT00004060
195908195908Fluorouracil Plus UCN-01 in Treating Patients With Advanced or Refractory Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: 7-hydroxystaurosporine|Drug: fluorouracilhttps://ClinicalTrials.gov/show/NCT00004059
19590919590912-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow DisorderTerminatedNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Diseases|Precancerous/Nonmalignant ConditionDrug: tetradecanoylphorbol acetatehttps://ClinicalTrials.gov/show/NCT00004058
195910195910Paclitaxel Plus L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors or LymphomasCompletedNo Results AvailableLymphoma|Unspecified Adult Solid Tumor, Protocol SpecificDrug: L-778,123|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00004057
195911195911Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCompletedNo Results AvailableLeukemiaBiological: filgrastim|Drug: asparaginase|Drug: cytarabine|Drug: daunorubicin hydrochloride|Drug: melphalan|Drug: thioguanine|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00004056
195912195912Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung CancerCompletedNo Results AvailableLung CancerBiological: filgrastim|Drug: paclitaxel|Drug: topotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00004055
195913195913Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate CancerCompletedHas ResultsProstate CancerDrug: bicalutamide|Drug: estramustine phosphate sodium|Drug: etoposide|Drug: flutamide|Drug: paclitaxel|Drug: Luteinizing hormone releasing hormone [LHRH] agonist|Radiation: Radiation therapy|Drug: warfarinhttps://ClinicalTrials.gov/show/NCT00004054
195914195914Vaccine Therapy in Treating Patients With Chronic Myelogenous LeukemiaCompletedNo Results AvailableLeukemiaBiological: QS21|Biological: bcr-abl peptide vaccinehttps://ClinicalTrials.gov/show/NCT00004052
195915195915Irinotecan in Treating Patients With Advanced Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: irinotecan hydrochloridehttps://ClinicalTrials.gov/show/NCT00004051
195916195916Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate CancerTerminatedNo Results AvailableProstate CancerBiological: Leuvectinhttps://ClinicalTrials.gov/show/NCT00004050
195917195917SR-45023A in Treating Patients With Locally Advanced or Metastatic Solid TumorsActive, not recruitingNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: apominehttps://ClinicalTrials.gov/show/NCT00004049
195918195918Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid CancerCompletedNo Results AvailableHead and Neck CancerBiological: filgrastim|Drug: doxorubicin hydrochloride|Procedure: autologous bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: indium In 111 monoclonal antibody MN-14|Radiation: yttrium Y 90 monoclonal antibody MN-14https://ClinicalTrials.gov/show/NCT00004048
195919195919Chemotherapy in Treating Patients Who Have Hematologic CancerCompletedNo Results AvailableLeukemia|Myelodysplastic SyndromesDrug: exatecan mesylatehttps://ClinicalTrials.gov/show/NCT00004047
195920195920Chemotherapy in Treating Women With Metastatic Breast CancerCompletedNo Results AvailableBreast CancerDrug: exatecan mesylatehttps://ClinicalTrials.gov/show/NCT00004046
195921195921Chemotherapy in Treating Patients With Prostate CancerCompletedNo Results AvailableProstate CancerDrug: exatecan mesylatehttps://ClinicalTrials.gov/show/NCT00004045
195922195922Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate CancerCompletedNo Results AvailableProstate CancerDietary Supplement: calcitriolhttps://ClinicalTrials.gov/show/NCT00004043
195923195923Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic CancerCompletedNo Results AvailableColorectal CancerBiological: monoclonal antibody F19|Radiation: iodine I 131 monoclonal antibody F19https://ClinicalTrials.gov/show/NCT00004042
195924195924Gene Therapy in Treating Patients With Recurrent Malignant GliomasCompletedNo Results AvailableBrain and Central Nervous System TumorsBiological: Ad5CMV-p53 gene|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00004041
195925195925Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After ChemotherapyWithdrawnNo Results AvailableLeukemia|Multiple Myeloma and Plasma Cell NeoplasmBiological: recombinant interferon alfa|Biological: rituximabhttps://ClinicalTrials.gov/show/NCT00004040
195926195926Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV LymphomaWithdrawnNo Results AvailableLymphomaBiological: recombinant interferon alfa|Biological: rituximab|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00004039
195927195927Gene Therapy Plus Chemotherapy in Treating Patients With Breast CancerCompletedNo Results AvailableBreast CancerBiological: Ad5CMV-p53 gene|Drug: chemotherapyhttps://ClinicalTrials.gov/show/NCT00004038
195928195928Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerTerminatedNo Results AvailableOvarian Cancer|Primary Peritoneal Cavity CancerDrug: docetaxelhttps://ClinicalTrials.gov/show/NCT00004037
195929195929Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerActive, not recruitingNo Results AvailableChronic Myeloproliferative Disorders|Drug/Agent Toxicity by Tissue/Organ|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Precancerous Condition|Unspecified Adult Solid Tumor, Protocol SpecificBiological: sargramostim|Drug: amifostine trihydrate|Drug: carboplatin|Drug: cyclophosphamidehttps://ClinicalTrials.gov/show/NCT00004036
195930195930Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic LeukemiaActive, not recruitingNo Results AvailableCardiac Toxicity|LeukemiaDrug: asparaginase|Drug: cytarabine|Drug: dexrazoxane hydrochloride|Drug: doxorubicin hydrochloride|Drug: leucovorin calcium|Drug: mercaptopurine|Drug: methotrexate|Drug: methylprednisolone|Drug: prednisolone|Drug: prednisone|Drug: therapeutic hydrocortisone|Drug: vincristine sulfate|Procedure: quality-of-life assessment|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00004034

* Görseller ve İçerik tekif hakkına sahip olabilir